CIK 0001429260 · Non-accelerated filer<br>Smaller reporting company
Fortress Biotech, Inc.
Sign in to watch- Ticker
- FBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 205157386
- Phone
- 781-652-4500
- Business address
- 1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
- Former names
- Fortress Biotech, Inc., CORONADO BIOSCIENCES INC
Securities
- FBIO Common Stock Nasdaq
- FBIOP 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock Nasdaq
- 4 Open-market buy 10% owner bought 418,410 shares at $0.72 ($301,255)
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Insider Changes in Ownership
- PRE 14A Proxy Proxy Statement (Preliminary)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Bylaws or fiscal year change
- CORRESP Other Correspondence Between Filers and SEC Staff
- SC 13D/A Stake Beneficial Ownership Report
- UPLOAD Other SEC-generated Letter
- 4 Insider Changes in Ownership
- 8-K Event Executive or director change · Shareholder vote results
- 8-K Event Material agreement · Shareholder rights changed
- 424B5 Offering Prospectus
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Delisting notice
- DEF 14A Proxy Proxy Statement
- DEFA14A Proxy Proxy Materials
- SC 13D/A Stake Beneficial Ownership Report
Page 11 of 45 · 886 filings